Feasibility trial for adjuvant chemotherapy with docetaxel plus cisplatin followed by single agent long-term administration of S-1 chemotherapy in patients with completely resected non-small cell lung cancer: Thoracic Oncology Research Group Study 0809

Feasibility trial for adjuvant chemotherapy with docetaxel plus cisplatin followed by single agent long-term administration of S-1 chemotherapy in patients with completely resected non-small cell lung cancer: Thoracic Oncology Research Group Study 0809

Bibliographic Details
Main Authors: Niho, S, Ikeda, N, Michimae, H, Suzuki, K, Sakai, H, Kaburagi, T, Minato, K, Kato, T, Okamoto, H, Seto, T, Hosomi, Y, Shimizu, K, Oshita, F, Kunitoh, H, Tsuboi, M, Takeuchi, M, Watanabe, K
Format: Online
Language:English
Published: Nature Publishing Group 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738148/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738148/

Similar Items